Stay updated on Efficacy & Safety of Two Doses of HIL-214 in Children Clinical Trial
Sign up to get notified when there's something new on the Efficacy & Safety of Two Doses of HIL-214 in Children Clinical Trial page.

Latest updates to the Efficacy & Safety of Two Doses of HIL-214 in Children Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe clinical trial record is available, detailing the HIL-214 study’s design, eligibility, locations, outcome measures, and posted study documents. It also indicates that the trial was terminated for lack of efficacy and is no longer recruiting.SummaryDifference51%

- Check16 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide banner announces NIH website transition updates and says that agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check30 days agoChange DetectedThe site revision marker in the footer changed from v3.7.1 to v3.7.2; the page otherwise remains a 403 Forbidden error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page is currently inaccessible due to a 403 error, replacing the usual study details with a permission issue. This reflects a permissions/server problem affecting the core content users expect on this page.SummaryDifference18%

Stay in the know with updates to Efficacy & Safety of Two Doses of HIL-214 in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of Two Doses of HIL-214 in Children Clinical Trial page.